Literature DB >> 16791593

Combined profile of the tandem repeats CAG, TA and CA of the androgen and estrogen receptor genes in breast cancer.

Andrei Anghel1, Marius Raica, Catalin Marian, Sorin Ursoniu, Oana Mitrasca.   

Abstract

PURPOSE: Case-control studies have reported inconsistent results concerning the association between polymorphisms in the androgen and estrogen receptor (ER) genes and breast cancer. While several studies investigated the association between the androgen receptor (AR) gene, CAG repeat and breast cancer, for the CA and TA repeats in the ER genes there are considerably fewer studies (one for CA and none for TA).
METHODS: We have investigated the potential link between three tandem repeats (CAG, TA, and CA) in the AR, ERs alpha and beta genes, respectively, and breast cancer. DNA was isolated from 153 invasive breast tumors and 318 controls, and the three tandem repeats were sized by polyacrylamide electrophoresis. Number of repeats in each allele and the total repeats of both alleles were taken as variables for classification into dichotomous groups using the median of each variable in the control group as cut-off point. Relationship between polymorphic tandem repeats and breast cancer was assessed by multivariate logistic regression models.
RESULTS: Three variables combined, longer CAGsum (> or =28), shorter TA (<23) and CA (<23) repeats could constitute a possible genetic profile associated with breast cancer.
CONCLUSIONS: Our results confirm previous reports regarding an association between longer CAG repeats and breast cancer. In addition to that, we found that the combination of long CAG, short TA and CA repeats are strongly associated with breast cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16791593     DOI: 10.1007/s00432-006-0121-9

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  50 in total

1.  Sex hormones and postmenopausal breast cancer: a prospective study in an adult community.

Authors:  C F Garland; N J Friedlander; E Barrett-Connor; K T Khaw
Journal:  Am J Epidemiol       Date:  1992-06-01       Impact factor: 4.897

2.  Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer.

Authors:  C Menin; G L Banna; G De Salvo; V Lazzarotto; A De Nicolo; S Agata; M Montagna; G Sordi; O Nicoletto; L Chieco-Bianchi; E D'Andrea
Journal:  Cancer Lett       Date:  2001-07-10       Impact factor: 8.679

3.  Improved measurement of androgen receptors in human breast cancer.

Authors:  O A Lea; S Kvinnsland; T Thorsen
Journal:  Cancer Res       Date:  1989-12-15       Impact factor: 12.701

4.  Association of polymorphism of human alpha oestrogen receptor gene with coronary artery disease in men: a necropsy study.

Authors:  T A Kunnas; P Laippala; A Penttilä; T Lehtimäki; P J Karhunen
Journal:  BMJ       Date:  2000-07-29

5.  The polymorphic CAG repeat of the androgen receptor gene: a potential role in breast cancer in women over 40.

Authors:  Y A Elhaji; B Gottlieb; R Lumbroso; L K Beitel; W D Foulkes; L Pinsky; M A Trifiro
Journal:  Breast Cancer Res Treat       Date:  2001-11       Impact factor: 4.872

6.  Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group.

Authors:  J A Cauley; F L Lucas; L H Kuller; K Stone; W Browner; S R Cummings
Journal:  Ann Intern Med       Date:  1999-02-16       Impact factor: 25.391

7.  Polymorphisms in the estrogen receptor beta gene and risk of breast cancer: no association.

Authors:  Asta Försti; Chunyan Zhao; Elisabeth Israelsson; Karin Dahlman-Wright; Jan-Ake Gustafsson; Kari Hemminki
Journal:  Breast Cancer Res Treat       Date:  2003-06       Impact factor: 4.872

8.  The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function.

Authors:  N L Chamberlain; E D Driver; R L Miesfeld
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971

9.  Serum sex hormone levels after menopause and subsequent breast cancer.

Authors:  F Berrino; P Muti; A Micheli; G Bolelli; V Krogh; R Sciajno; P Pisani; S Panico; G Secreto
Journal:  J Natl Cancer Inst       Date:  1996-03-06       Impact factor: 13.506

10.  CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers.

Authors:  L Kadouri; D F Easton; S Edwards; A Hubert; Z Kote-Jarai; B Glaser; F Durocher; D Abeliovich; T Peretz; R A Eeles
Journal:  Br J Cancer       Date:  2001-07-06       Impact factor: 7.640

View more
  4 in total

1.  Selected estrogen receptor 1 and androgen receptor gene polymorphisms in relation to risk of breast cancer and fibrocystic breast conditions among Chinese women.

Authors:  Lori C Sakoda; Christie R Blackston; Jennifer A Doherty; Roberta M Ray; Ming Gang Lin; Dao Li Gao; Helge Stalsberg; Ziding Feng; David B Thomas; Chu Chen
Journal:  Cancer Epidemiol       Date:  2010-09-17       Impact factor: 2.984

Review 2.  Trinucleotide repeat expansions in human breast cancer-susceptibility genes: relevant targets for aspirin chemoprevention?

Authors:  M A Altinoz; N E Tunalı
Journal:  Clin Transl Oncol       Date:  2015-07-22       Impact factor: 3.405

3.  Analysis of genome instability in breast cancer.

Authors:  Eldamária de Vargas Wolfgramm; Lyvia Neves Rebello Alves; Elaine Stur; Thaís Tristão Tovar; Mariana Penha De Nadai Sartori; Allan Kardec de Castro Neto; Iúri Drumond Louro
Journal:  Mol Biol Rep       Date:  2012-11-27       Impact factor: 2.316

4.  Microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes and breast cancer risk in African American and Nigerian women.

Authors:  Yonglan Zheng; Dezheng Huo; Jing Zhang; Toshio F Yoshimatsu; Qun Niu; Olufunmilayo I Olopade
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.